Zenas BioPharma, Inc. License Agreements
6 Contracts & Agreements
- License Agreement by and between the Registrant and Bristol-Myers Squibb Company, dated as of August 30, 2023 (Filed With SEC on August 22, 2024)
- Second Amendment to License Agreement by and between Zenas BioPharma, Inc. and Xencor, Inc., dated May 27, 2021 (Filed With SEC on August 22, 2024)
- First Amendment to License Agreement by and between Zenas BioPharma (Cayman) Limited and Xencor, Inc., dated May 27, 2021 (Filed With SEC on August 22, 2024)
- License Agreement by and between Zenas BioPharma (Cayman) Limited and Xencor, Inc., dated May 27, 2021 (Filed With SEC on August 22, 2024)
- First Amendment to License Agreement by and between Zenas BioPharma, Inc. and Xencor, Inc., dated June 24, 2024 (Filed With SEC on August 22, 2024)
- License Agreement by and between Zenas BioPharma (Cayman) Limited and Xencor, Inc., dated September 23, 2020 (Filed With SEC on August 22, 2024)
